A detailed history of Neuberger Berman Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,992,845 shares of ZTS stock, worth $364 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,992,845
Previous 2,896,880 31.21%
Holding current value
$364 Million
Previous $490 Million 29.52%
% of portfolio
0.29%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $132 Million - $162 Million
-904,035 Reduced 31.21%
1,992,845 $345 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $480 Million - $579 Million
2,896,880 New
2,896,880 $490 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $1.21 Million - $1.6 Million
8,006 Added 0.28%
2,886,104 $570 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $1.69 Million - $1.95 Million
10,096 Added 0.35%
2,878,098 $501 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $82 Million - $94.9 Million
509,417 Added 21.6%
2,868,002 $494 Million
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $9.49 Million - $11.4 Million
-65,237 Reduced 2.69%
2,358,585 $393 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $7.99 Million - $9.59 Million
-60,909 Reduced 2.45%
2,423,822 $355 Million
Q3 2022

Nov 15, 2022

BUY
$148.29 - $182.55 $12 Million - $14.7 Million
80,767 Added 3.36%
2,484,731 $368 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $12 Million - $15.4 Million
-77,080 Reduced 3.11%
2,403,964 $413 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $8.54 Million - $11 Million
-47,085 Reduced 1.86%
2,481,044 $467 Million
Q4 2021

Feb 11, 2022

SELL
$193.69 - $247.03 $3.28 Million - $4.18 Million
-16,928 Reduced 0.67%
2,528,129 $615 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $11.3 Million - $12.5 Million
-59,667 Reduced 2.29%
2,545,057 $493 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $2.21 Million - $2.67 Million
14,180 Added 0.55%
2,604,724 $485 Million
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $46.5 Million - $54.7 Million
-322,747 Reduced 11.08%
2,590,544 $408 Million
Q4 2020

Feb 10, 2021

SELL
$157.07 - $174.35 $19.4 Million - $21.6 Million
-123,654 Reduced 4.07%
2,913,291 $482 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $1.32 Million - $1.6 Million
9,650 Added 0.32%
3,036,945 $502 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $16.4 Million - $20.9 Million
146,601 Added 5.09%
3,027,295 $415 Million
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $5.88 Million - $9.19 Million
63,404 Added 2.25%
2,880,694 $339 Million
Q4 2019

Feb 12, 2020

SELL
$116.25 - $133.25 $43,942 - $50,368
-378 Reduced 0.01%
2,817,290 $373 Million
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $139,586 - $159,253
1,240 Added 0.04%
2,817,668 $351 Million
Q2 2019

Aug 13, 2019

SELL
$97.98 - $114.28 $2.98 Million - $3.47 Million
-30,402 Reduced 1.07%
2,816,428 $320 Million
Q1 2019

May 13, 2019

SELL
$81.56 - $100.67 $8.95 Million - $11 Million
-109,692 Reduced 3.71%
2,846,830 $287 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $4.07 Million - $4.89 Million
-51,326 Reduced 1.71%
2,956,522 $253 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $4.55 Million - $5.08 Million
-54,529 Reduced 1.78%
3,007,848 $275 Million
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $38.6 Million - $43.1 Million
-482,815 Reduced 13.62%
3,062,377 $261 Million
Q1 2018

May 08, 2018

SELL
$71.51 - $84.69 $3.3 Million - $3.9 Million
-46,104 Reduced 1.28%
3,545,192 $296 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $53.5 Million - $61.6 Million
-846,342 Reduced 19.07%
3,591,296 $259 Million
Q3 2017

Nov 15, 2017

BUY
$59.73 - $65.4 $265 Million - $290 Million
4,437,638
4,437,638 $283 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.